Digital Subtraction Angiography Systems Market

The market for Digital Subtraction Angiography Systems was estimated at $2.1 billion in 2025; it is anticipated to increase to $3.3 billion by 2030, with projections indicating growth to around $5.2 billion by 2035.

Report ID:DS1801126

Author:Debadatta Patel - Senior Consultant

Published Date:January 2025

Datatree

Life Science

Medical Device

Digital Subtraction Angiography Systems

Customization Available

Digital Subtraction Angiography Systems - 2025-2035

Market Outlook
Market Key Insights
Growth Opportunity
Market Dynamics
Application
Recent Development
Impact Analysis

Report Summary

Market Data

Methodology

Table of Contents

Report Summary

Market Data

Methodology

Table of Contents

Global Digital Subtraction Angiography Systems Market Outlook

Revenue, 2025

$2.1B

Forecast, 2035

$5.2B

CAGR, 2026 - 2035

9.4%

The Digital Subtraction Angiography Systems (DSA) industry revenue is expected to be around $2.1 billion in 2026 and expected to showcase growth with 9.4% CAGR between 2026 and 2035. Advanced vascular imaging and image guided therapies have benefited from the growth in Digital Subtraction Angiography Systems, with these systems forming a core component in current interventional radiology and cardiology facilities. These systems are being installed in various hospitals and medical facilities. They provide the necessary infrastructure to support complex interventional cardiology and neuro interventional procedures. With the increase in the incidence of cardiovascular and neurovascular disease, plus an older population, coupled with a preference for minimally invasive procedures, there is an increasing investment in equipment that can offer superior vascular imaging and interventional radiology services. Applications in cardiology and neurology account for 70% of current demand for Digital Subtraction Angiography. This reflects the crucial role of DSA in coronary, neurovascular devices and structural heart imaging procedures. In the year 2025 the of fixed system configurations was the market leader, achieving sales of $1.73 billion. The rise of these systems can be attributed to health services making use of hybrid cath labs and operating rooms. The aim is to achieve greater efficiency in clinical work, maximise the use made of these facilities and coordinate different departments working together to manage different cases.

Highly advanced medical imaging technology comprises digital subtraction angiography. This procedure incorporates real time video and digital subtraction techniques to greatly improve the ability of doctors to visualise blood vessels, thus helping doctors diagnose conditions more accurately. These methods are widely used in cardiology, neurology, cancer treatment and the diagnosis of diseases of the limbs. High levels of diagnostic confidence are enabled through the combination of such technologies as rotational 3D imaging, motion compensation, and dose reduction tools. Additionally, integration with systems for medical navigation and hospital information is provided. This facilitates image guided intervention while keeping the radiation used to a minimum. These systems are crucial in many interventional radiology procedures including angioplasty for heart arteries, aneurysm treatment, aneurysm repair and stroke. It also covers treating hemorrhages, peripheral artery disease and structural heart conditions. Consequently, this technology has formed the foundation for various medical imaging procedures. There is a growing demand driven by trends such as the development of facilities which combine imaging and treatment in one hybrid operating theatre, advances in neurovascular imaging techniques, the quicker than expected adoption of medical imaging technology in developing countries and an increase in the use of computer algorithms to interpret images and so improve diagnostic results.

Digital Subtraction Angiography Systems market outlook with forecast trends, drivers, opportunities, supply chain, and competition 2025-2035 — Digital Subtraction Angiography Systems Market Outlook

Market Key Insights

Digital subtraction angiography equipment is expected to see an increase in demand from $2.1 billion in 2025 to $5.2 billion by 2035. Across vascular imaging, interventional radiology and cardiovascular disease diagnosis, demand has been on the increase with the resulting effect of a CAGR of 9.4%.
The healthcare imaging market has a limited number of suppliers, GE Healthcare and Siemens Healthcare being the largest of these.
The markets of the US and Japan which are leaders in the digital subtraction angiography systems market, are expected to achieve a compound annual growth rate of 6.9% to 9.9% between 2025 and 2030.
The countries with the highest growth rate will be the emerging markets of Saudi Arabia, India and Brazil, growing at a compound rate of 9 11.8%.
The healthcareindustry'sslow rate of adopting digital transformation techniques has opened up revenue opportunities for adjacent sectors such as magnetic resonance angiography, intravascular ultrasound technology and computed tomography angiography. These technologies are being used in cardiology and oncology, potentially earning $167 million from existing digital subtraction angiography systems.
Digital subtraction angiography systems will experience a revenue increase of $3.1 billion between 2025 and 2035. However the sector of the market concerned with oncology and neurology will have the greatest share.
As cardiovascular conditions are on the increase coupled with the expanding use of minimally invasive interventions along with the increasing use of advanced imaging software and AI for better vascular visualisation, digital subtraction angiography systems will see an expansion of 146% between 2025 and 2035.

Digital Subtraction Angiography Systems - Country Share Analysis

Opportunities in the Digital Subtraction Angiography Systems

There is also a growing need in China for Digital Subtraction Angiography equipment as a result of the rapid expansion of hospitals equipped to treat strokes and units which specialise in neurovascular disorders. A considerable number of smaller centres still use older X ray equipment, offering both new equipment sales and installation opportunities, particularly in respect of fixed systems. By 2030, it is predicted that the worldwide fixed DSA market will be worth $2.63 billion. This is a rise from $1.73 billion in 2025. It is forecast that China will be the largest investor in radiology suites in the next few years.

Growth Opportunities in North America and Asia Pacific

Across North America, DSA equipment is mainly driven by cardiology departments employing high resolution imaging. These centres provide a range of advanced digital angiography facilities. These facilities are specifically designed to assist in complex heart and vascular procedures and are frequently found in hospitals with cath labs and operating theatres. In high volume centres, workflow can be improved and minimally invasive procedures streamlined through the use of dose efficient AI enhanced neurovascular imaging solutions and cardiovascular imaging. These solutions replace legacy interventional radiology equipment. Rather than simply competing on hardware specifications, companies are differentiating their premium products through various features such as enterprise imaging systems, hospital capital equipment planning and image guided therapy software. Comprehensive service contracts are also offered to customers. This market will be driven by stringent regional standards for the quality and safety of treatments and several other regional factors. These factors include reimbursement for interventions which are guided by images, rapid expansion in networks for the treatment of strokes and hospital consolidation. This consolidation favours Digital Subtraction Angiography systems which can be used across multiple sites.

As markets in the Asia Pacific continue to grow, hospitals are increasingly looking to digital subtraction angiography systems. There is presently high demand for these systems from cardiology departments in hospitals. Neurology is another region seeing increased adoption. Installations in rapidly developing metropolitan and smaller towns offer significant opportunities. Digital angiography systems which could cut costs should also be looked into. These could be arranged in a compact form to be used for treatments in these multi purpose operation rooms. Global premium brands and agile regional manufacturers coexist to shape competition in this equipment sector. This is notably the case for interventional radiology equipment, with the deployment of these machines typically via public tenders. They compete on service, lifecycle costs and price performance. The regions key growth drivers are the increasing demand for cardiovascular devices and cancer treatments. In addition, there are government backed healthcare initiatives which are investing in cancer and stroke centres. Furthermore there is an expanding medical tourism industry and also a move towards image guided therapy which requires that hospitals modernise their cath labs and hybrid operating theatres with digital subtraction angiography systems that are future proof.

Market Dynamics and Supply Chain

Driver: Rising Prevalence of Cardiovascular Diseases and Expanding Minimally Invasive Procedures

The increasing global incidence of cardiovascular diseases such as coronary artery disease, peripheral artery disease, and aneurysms is also a major growth factor driving demand for digital subtraction angiography systems. With more patients requiring precise vascular imaging for diagnosis and treatment, hospitals and cardiology centers are also investing in advanced DSA technologies. Separately, the rapid adoption of minimally invasive procedures, including catheter-based interventions and endovascular therapies, is also fueling demand for high-resolution, real-time imaging. DSA systems with flat-panel detectors, enhanced frame rates, and superior contrast resolution are also critical for guiding these procedures safely and accurately. Innovations like 3D rotational angiography and automated image subtraction further improve visualization, reduce radiation exposure, and optimize procedural efficiency.

Technological advancements in software and artificial intelligence have also improved the capabilities of DSA systems significantly. AI-enabled image processing allows automatic detection of vascular abnormalities, enhances contrast visualization, and reduces motion artifacts. Advanced post-processing software supports 3D reconstruction, aiding clinicians in pre-procedure planning and improving diagnostic accuracy. These innovations streamline workflow, reduce procedural time, and improve patient outcomes, making DSA systems increasingly attractive to hospitals and specialized imaging centers seeking efficiency and precision in vascular imaging.

Restraint: High Equipment and Maintenance Costs Limit Adoption in Smaller Healthcare Facilities

One major restraint for digital subtraction angiography systems is the high upfront cost of advanced imaging equipment and the ongoing expense of maintenance and software upgrades. Smaller hospitals and clinics, particularly in emerging markets, may delay or avoid purchases, preferring lower‑cost imaging modalities such as ultrasound or basic fluoroscopy. This cost barrier suppresses demand and slows revenue growth for DSA vendors, especially outside large urban centers where budgets are constrained and capital investment cycles are long.

Opportunity: Integration of fixed DSA in hybrid operating rooms within European tertiary hospitals and Expansion of portable Digital Subtraction Angiography Systems for minimally invasive cardiovascular procedures in India

The tertiary care centres in Europe are making a significant investment in fixed DSA equipped in hybrid operating theatres where surgery and endovascular treatments can be combined. Complex cardiac and vascular procedures in many operating theatres at present are impeded due to the lack of real time imaging of the vascular system. The installation of ceiling mounted imaging systems makes it possible to combine medical facilities like cath labs and operating rooms. This enables a reduction in facility costs and an increase in lab productivity. In Europe, the demand for such platforms will be greater than for portable systems, particularly in universities and reference centres.

As India continues to see an increase in the number of portable digital subtraction angiography units being installed in its district and secondary hospitals, more people are gaining access to minimally invasive treatments for coronary and peripheral disease. The use of cardiovascular imaging technology is still limited in non urban hospitals. This means that the demand for portable cardiovascular imaging equipment is substantial. Portable digital subtraction angiography units are expected to reach $0.70 billion by 2030 from $0.39 billion in 2025 with a compound annual growth rate of 12.31%. This particular technology has the highest growth rate among portable platforms in this region.

Challenge: Radiation Exposure Concerns and Regulatory Requirements Slow Clinical Utilization

Another key challenge is the concern over patient and operator radiation exposure, which influences clinician preferences and procurement decisions. Strict safety standards and regulatory requirements for radiation dose monitoring and protection increase operational complexity and costs. For example, cardiology and interventional radiology units may limit DSA use in favor of non‑radiative imaging like MRI or CT angiography when clinically appropriate, which can reduce procedural volumes and impact DSA market expansion.

Supply Chain Landscape

Component Manufacturing

Shimadzu CorporationCanon Medical Systems

Digital Subtraction Angiography

GE HealthcareSiemens Healthineers

DSA Systems Distribution

Philips HealthcareGE Healthcare

Clinical End Users

HospitalsDiagnostic Imaging CentersCardiology Clinics

Component Manufacturing

Shimadzu CorporationCanon Medical Systems

Digital Subtraction Angiography

GE HealthcareSiemens Healthineers

DSA Systems Distribution

Philips HealthcareGE Healthcare

Clinical End Users

HospitalsDiagnostic Imaging CentersCardiology Clinics

Digital Subtraction Angiography Systems - Supply Chain

Use Cases of Digital Subtraction Angiography Systems in Vascular Imaging & Interventional Radiology

Vascular Imaging : In vascular imaging, digital subtraction angiography systems are the standard for detailed visualization of blood vessels, particularly for detecting stenosis, aneurysms, and occlusions. High‑resolution biplane and monoplane DSA units are widely adopted in diagnostic labs and cath labs due to their ability to subtract bone and soft tissue, leaving clear vascular maps. Philips Healthcare and Shimadzu Medical Systems lead this segment with advanced imaging algorithms, comprehensive software suites, and strong clinical support networks that boost diagnostic accuracy and clinician confidence.

Interventional Radiology : DSA play a pivotal role in interventional radiology by providing real‑time, high‑contrast vascular imaging that guides minimally invasive procedures. Flat‑panel detector DSA systems are commonly used due to their superior image clarity and rapid frame rates, enabling precise catheter navigation and device placement. Leading providers such as Siemens Healthineers, Canon Medical Systems, and GE Healthcare offer robust platforms that enhance procedural efficiency, reduce contrast usage, and improve clinical outcomes in complex interventional suites.

Cardiovascular Disease Diagnosis : For cardiovascular disease diagnosis, DSA enable clinicians to assess coronary arteries and peripheral vasculature with exceptional precision. Systems equipped with advanced motion correction and low contrast imaging are preferred, as they improve visualization during complex cardiac assessments. Top players including Toshiba (Canon) and Siemens Healthineers provide integrated DSA solutions that combine imaging excellence with workflow efficiency. These systems help cardiologists identify blockages and plan interventional strategies, supporting timely treatment decisions and better patient outcomes.

Recent Developments

Recent developments in digital subtraction angiography systems emphasize flat-panel detectors and AI-enhanced angiographic imaging to boost clarity and reduce radiation in complex vascular procedures. Integration with interventional radiology suites and hybrid operating rooms supports multimodal workflows and minimally invasive therapies. A key market trend is the shift toward real-time 3D imaging, improving diagnostic precision and procedural guidance. This trend drives demand across healthcare imaging equipment, benefitting OEMs, software developers, and advanced therapy device makers.

January 2025 : GE Healthcare launched the Allia IGS 7 DSA system featuring robotic-assisted C-arm positioning and AI-driven vessel roadmapping to enhance precision in peripheral and oncology interventions.

October 2024 : Siemens Healthineers received FDA clearance for its ARTIS icono ceiling angiography system, enabling its commercial distribution in the United States.

January 2024 : Siemens Healthineers introduced the ARTIS icono platform with enhanced imaging and workflow features for minimally invasive procedures.

Impact of Industry Transitions on the Digital Subtraction Angiography Systems Market

As a core segment of the Medical Device industry, the Digital Subtraction Angiography Systems market develops in line with broader industry shifts. Over recent years, transitions such as Digital Transformation Advances in Healthcare and Integration with Hybrid Interventions have redefined priorities across the Medical Device sector, influencing how the Digital Subtraction Angiography Systems market evolves in terms of demand, applications and competitive dynamics. These transitions highlight the structural changes shaping long-term growth opportunities.

Digital Transformation Advances in Healthcare

The slow pace of digital innovation in the DSA sector highlights a growing need for digital transformation, creating opportunities for alternative imaging techniques such as MRA, IVUS, and CT angiography to generate higher revenues. Current competitors are positioned to capture a market worth $167 million by strengthening their foothold in cardiology and oncology applications. A major consideration for companies operating in digital subtraction angiography is the urgency to advance digitalisation and adopt more sophisticated imaging technologies. If firms do not adapt their business models accordingly, they risk losing significant revenue and market share. This underscores the importance for healthcare businesses to implement timely digital transformation initiatives to remain competitive and sustain long-term growth.

Integration with Hybrid Interventions

DSA systems are increasingly being integrated into hybrid operating rooms and multi-modality interventional suites, combining angiography with CT, ultrasound, and robotic-assisted platforms. This transition supports minimally invasive, image-guided therapies across cardiology, oncology, and vascular surgery, improving procedural accuracy and patient outcomes. The impact extends to construction and infrastructure industries through demand for specialized hybrid OR installations, as well as to robotics and navigation technology firms supplying precision-guided intervention tools. Additionally, pharmaceutical and medical device companies benefit from enhanced compatibility between DSA-guided procedures and advanced catheters, stents, and embolic agents, accelerating adoption of image-guided therapies across emerging and developed healthcare markets.